This question has been answered by the relevant Government Department.
Question text
Baroness Ritchie of Downpatrick to ask His Majesty's Government what discussions they have had with the National Institute for Health and Care Excellence regarding the suitability of its Single Technology Appraisal pathway to evaluate the cost-effectiveness of potentially one-time treatments such as novel cell and gene therapies for rare diseases. HL5711
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.
Member's Registered Interests
There are no interests to show.
Main Member
Baroness Ritchie of Downpatrick
Labour
Life peer